1. Academic Validation
  2. Novel Pyrone-Based Biofilm Inhibitors against Azole-Resistant

Novel Pyrone-Based Biofilm Inhibitors against Azole-Resistant

  • ACS Omega. 2025 Aug 11;10(32):36441-36454. doi: 10.1021/acsomega.5c04793.
Ji-Eun Yang 1 Jin-Hyung Lee 2 Bharath Reddy Boya 2 Yong-Guy Kim 2 Youngjoo Byun 1 3 Jintae Lee 2
Affiliations

Affiliations

  • 1 College of Pharmacy, Korea University, 2511 Sejong-ro, Sejong 30019, Republic of Korea.
  • 2 School of Chemical Engineering, Yeungnam University, Gyeongsan, Kyeongbuk 38541, Republic of Korea.
  • 3 Interdisciplinary Major Program in Innovative Pharmaceutical Sciences, Korea University, Sejong 30019, Republic of Korea.
Abstract

is an opportunistic fungus that is pathogenic in immunocompromised patients with life-threatening diseases such as HIV and Cancer. is the most common Fungal species isolated from biofilms formed on implanted medical devices or on human tissue. Biofilm development of is mainly driven by a transition from yeast to hyphal form involving core proteins such as HWP and ALS. We designed and synthesized novel α-pyrone-based analogues to investigate their potential in inhibiting biofilm formation and hyphal development of . Among the synthesized compounds, three compounds (6f, 6j, and 6n) significantly inhibited biofilm formation and reduced cell aggregation and hyphal formation in a dose-dependent manner. These compounds had minimal effects on planktonic cell growth while significantly reducing biofilm formation at 20-50 μg/mL, suggesting novel candidate compounds for managing drug-resistant strains of . The three compounds may represent promising therapeutic options with potential synergistic effects when combined with existing Antifungal agents.

Figures
Products